Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 2:37 pm Purchase | 2025-09-30 | 13G | YORKVILLE ACQUISITION CORP CL MCGA | Anson Funds Management LP | 1,772,150 9.900% | 495,342 (+38.80%) | Filing History |
| 2025-11-14 2:30 pm Sale | 2025-09-30 | 13G | TAOWEAVE, INC. TWAV | Anson Funds Management LP | 123,439 4.900% | -23,616 (-16.06%) | Filing History |
| 2025-11-14 2:24 pm Sale | 2025-09-30 | 13G | APPLIED DNA SCIENCES INC P APDN | Anson Funds Management LP | 67,828 4.900% | -505,710 (-88.17%) | Filing History |
| 2025-11-14 2:19 pm Sale | 2025-09-30 | 13G | NANO LABS LTD SHS NA | Anson Funds Management LP | 1,240,920 4.900% | -567,520 (-31.38%) | Filing History |
| 2025-11-14 12:27 pm Sale | 2025-09-30 | 13G | ZETA NETWORK GROUP ZNB | Anson Funds Management LP | 0 0.000% | -2,256 (Position Closed) | Filing History |
| 2025-08-14 9:55 pm Purchase | 2025-06-30 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Anson Funds Management LP | 27,125 0.100% | 23,072 (+569.26%) | Filing History |
| 2025-08-14 9:53 pm Purchase | 2025-06-30 | 13G | NRX PHARMACEUTICALS INC NE NRXP | Anson Funds Management LP | 1,604,975 9.300% | 425,914 (+36.12%) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | 22ND CENTY GROUP INC PAR $ XXII | Anson Funds Management LP | 2,009 4.900% | 1,983 (+7626.92%) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | CHANSON INTL HLDG USD CHSN | Anson Funds Management LP | 487 9.900% | 487 (New Position) | Filing History |
| 2025-08-14 9:51 pm Purchase | 2025-06-30 | 13G | YORKVILLE ACQUISITION CORP CL MCGA | Anson Funds Management LP | 1,276,808 8.300% | 1,276,808 (New Position) | Filing History |
| 2025-08-14 9:50 pm Sale | 2025-06-30 | 13G | GREENWAVE TECHNOLOGY SOLUTIONS GWAV | Anson Funds Management LP | 29,206 4.900% | -14,823 (-33.67%) | Filing History |
| 2025-08-14 9:48 pm Purchase | 2025-06-30 | 13G | DIGITAL ALLY INC DGLY | Anson Funds Management LP | 15,706 0.030% | 15,610 (+16260.42%) | Filing History |
| 2025-08-14 9:48 pm Sale | 2025-06-30 | 13G | SPERO THERAPEUTICS INC SPRO | Anson Funds Management LP | 1,615,469 2.900% | -2,134,981 (-56.93%) | Filing History |
| 2025-08-14 9:47 pm Sale | 2025-06-30 | 13G | FEMTO TECHNOLOGIES INC FMTOF | Anson Funds Management LP | 0 0.000% | -324,808 (Position Closed) | Filing History |
| 2025-08-14 9:45 pm Purchase | 2025-06-30 | 13G | TAOWEAVE, INC. TWAV | Anson Funds Management LP | 147,055 9.900% | 147,055 (New Position) | Filing History |
| 2025-08-14 9:43 pm Sale | 2025-06-30 | 13G | SELLAS LIFE SCIENCES GROUP INC SLS | Anson Funds Management LP | 5,225,948 4.900% | -2,353,147 (-31.05%) | Filing History |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | APPLIED DNA SCIENCES INC P APDN | Anson Funds Management LP | 573,538 8.200% | 364,069 (+173.81%) | Filing History |
| 2025-08-14 9:41 pm Sale | 2025-06-30 | 13G | HEPION PHARMACEUTICALS INC HEPA | Anson Funds Management LP | 576,482 4.900% | -19,237 (-3.23%) | Filing History |
| 2025-08-14 9:37 pm Purchase | 2025-06-30 | 13G | NANO LABS LTD SHS NA | Anson Funds Management LP | 1,808,440 8.700% | 1,808,440 (New Position) | Filing History |
| 2025-07-24 3:53 pm Unchanged | 2025-07-22 | 13D | MEI PHARMA INC MEIP | Anson Funds Management LP | 1,093,188 3.700% | 0 (Unchanged) | Filing History |